STOCK TITAN

HNGE (HNGE) Form 144 details insider plan to sell 2,614 Class A shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

HNGE shareholders filed a Form 144 indicating an intent to sell 2,614 Class A shares through Merrill Lynch on the NYSE. The planned sale has an aggregate market value of 130,490.88, with Class A shares outstanding reported at 37,919,155. These shares were originally acquired from the issuer in a private placement on 02/04/2020 and paid for in cash on the same date.

Over the past three months, affiliated holders have already sold several large Class A blocks. Bessemer Venture Partners X LP reported sales including 373,955 shares on 11/18/2025 for gross proceeds of 14,976,898, 103,160 shares on 11/26/2025 for 4,979,533.2, and 23,176 shares on 11/28/2025 for 1,162,403.87. Bessemer Venture Partners X Institutional LP reported sales including 351,045 shares on 11/18/2025 for 14,059,352, 96,840 shares on 11/26/2025 for 4,674,466.8, and 21,757 shares on 11/28/2025 for 1,091,233.21.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for HNGE disclose?

The filing discloses that a shareholder plans to sell 2,614 Class A shares of HNGE on the NYSE through broker Merrill Lynch, with an aggregate market value of 130,490.88.

How many HNGE Class A shares are outstanding in this filing?

The filing reports that 37,919,155 Class A shares are outstanding.

When and how were the HNGE shares being sold acquired?

The 2,614 Class A shares were acquired on 02/04/2020 in a private placement from the issuer and were paid for in cash on the same date.

What recent HNGE share sales by Bessemer Venture Partners X LP are listed?

Bessemer Venture Partners X LP sold Class A shares including 373,955 on 11/18/2025 for 14,976,898, 103,160 on 11/26/2025 for 4,979,533.2, and 23,176 on 11/28/2025 for 1,162,403.87 in gross proceeds.

What recent HNGE share sales by Bessemer Venture Partners X Institutional LP are listed?

Bessemer Venture Partners X Institutional LP sold Class A shares including 351,045 on 11/18/2025 for 14,059,352, 96,840 on 11/26/2025 for 4,674,466.8, and 21,757 on 11/28/2025 for 1,091,233.21 in gross proceeds.

What representation does the selling holder make in this HNGE Form 144?

The selling holder represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

On which exchange and through which broker are the 2,614 HNGE shares expected to be sold?

The planned sale of 2,614 Class A shares is listed for the NYSE through Merrill Lynch at One Bryant Park, New York, NY 10036.
Hinge Health, Inc.

NYSE:HNGE

HNGE Rankings

HNGE Latest News

HNGE Latest SEC Filings

HNGE Stock Data

3.79B
34.51M
8.08%
132.02%
1.61%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SAN FRANCISCO